APA (7th ed.) Citation

A, C., G, B., HH, V. A., J, F., AM, K., Z, A., . . . J, A. (2018). Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation. Molecular therapy : the journal of the American Society of Gene Therapy, 26(2), 354. https://doi.org/10.1016/j.ymthe.2017.12.001

Chicago Style (17th ed.) Citation

A, Capsomidis, et al. "Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation." Molecular Therapy : The Journal of the American Society of Gene Therapy 26, no. 2 (2018): 354. https://doi.org/10.1016/j.ymthe.2017.12.001.

MLA (9th ed.) Citation

A, Capsomidis, et al. "Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 26, no. 2, 2018, p. 354, https://doi.org/10.1016/j.ymthe.2017.12.001.